Multimorbidity
Conditions
Interventions
Group 1: Analysis of medication at admission and discharge, pharmaceutical recommendation, conference with physicians
Group 2: Analysis of the medication at admission and discharge
Sponsors
Helios Universitätsklinikum Wuppertal
Eligibility
Sex/Gender
All
Age
70 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria are the prescription of at least five medications, age of 70 years or above, written informed consent and inpatient stay at Helios Klinikum Schwelm during study time
Exclusion criteria
Exclusion criteria: - no written informed consent - Patient not able to give an Agreement - life expectancy less than 48 hours - palliative patients with a life expectancy less than one month - communication problems (deaf and dumb/blind) - inclusion in the study in the last three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Primary endpoint is a drug related Problem (DRP) defined as one of the following: - potentially inappropriate medication (PIM) in the PRISCUS-list - drug-drug-interaction (ABDA-database "simultaneous application not recommended" or more severe) - adverse drug reaction (ADR) - one drug without indication | — |
Secondary
| Measure | Time frame |
|---|---|
| - number of drugs per Patient - number of PRISCUS-PIM - number of drugs not adapted to renal function - number of drug-drug-interactions - number of drugs without indication - number and kind of adverse drug reaction - MAI-Score | — |
Countries
Germany
Contacts
Public ContactPetra A. Thürmann
Helios Universitätsklinikum Wuppertal Philipp Klee-Institut
Outcome results
None listed